Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Vir's Chief Executive Officer, will present at the J.P. Morgan 2024 42nd Annual Healthcare Conference on Wednesday, January 10,at 3:45 p.m. PT / 6:45 p.m. ET.
A live webcast of the presentation can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there for 30 days.
About Vir Biotechnology
Vir Biotechnology, Inc. is an immunology company focused on combining cutting-edge technologies to treat and prevent infectious diseases and other serious conditions. Vir has assembled two technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current clinical development pipeline consists of product candidates targeting hepatitis delta and hepatitis B viruses and human immunodeficiency virus. Vir has several preclinical candidates in its pipeline, including those targeting influenza A and B, COVID-19, RSV/MPV and HPV. Vir routinely posts information that may be important to investors on its website.
Canadian Radio-television and Telecommunications Commission (CRTC)
Today, the CRTC is taking action to bring high-speed fibre Internet to four remote Inuit communities in Nunavut, including one official language minority community. This is the first...
As Owner and Founder of Digital Marketing for Plumbers by Online Advantages, Matt Maglodi is devoted to making sure his website is kept up to date with the most current and useful information about digital marketing services for plumbers.
To help...
The global mobile robot charging station market size is estimated to grow by USD 817.9 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 40.15% during the forecast period. Reduced cost price of...
The global industrial vibration sensor market size is estimated to grow by USD 4.11 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 8.96% during the forecast period. Growing need for workplace...
The global body worn camera market size is estimated to grow by USD 1.25 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 21.49% during the forecast period. High demand for adventure tourism is driving...
